The U.S. legal system has long assumed that all testimony is not equally credible, that some witnesses are more reliable than others. In tough cases with child witnesses, it assumes adult witnesses to be more reliable. But what if the legal system had it wrong?

Researchers Valerie Reyna, human development professor, and Chuck Brainerd, human development and law school professor-- both from Cornell University -- argue that like the two-headed Roman god Janus, memory is of two minds -- that is, memories are captured and recorded separately and differently in two distinct parts of the mind.

In a new international study of 16 countries published in Science, economists studied the extent to which some people will sacrifice personal gain to benefit the wider public, while ‘freeloaders’ try to take advantage of their generosity.

Marked national differences arose when freeloaders were punished for putting their own interests ahead of the common good. And whether they accepted their punishment or retaliated in kind depended on what kind of society they lived in, the researchers found.

In countries like the USA, Switzerland and the UK, freeloaders accepted their punishment and became much more co-operative. But in countries based on more authoritarian and parochial social institutions such as Oman, Saudi Arabia, Greece and Russia, the freeloaders took revenge — retaliating against those who had punished them.

Stopping and cooling most of the atoms of the periodic table is now possible using a pair of techniques developed by physicist Mark Raizen at The University of Texas at Austin.

Raizen stopped atoms by passing a supersonic beam through an “atomic coilgun” and cooled them using “single-photon cooling.”

The techniques are a major step forward in atomic physics and have a variety of scientific and technological applications. They could be used to determine the mass of the neutrino, which is the primary candidate for dark matter.

A team of bioinformaticians at the Université de Montréal (UdeM) report in Nature the discovery of a structural alphabet that can be used to infer the 3D structure of ribonucleic acid (RNA) from sequence data, providing new tools to understand the role of this important class of cellular regulators.

The folding of a single-stranded RNA molecule is determined by the interactions between its constituent nucleotides. The classical approach to RNA modelling suffers from an important limitation: it only takes into account the canonical Watson-Crick interactions A:U and G:C, that is those where the nucleotides are facing each other.

The non-canonical Hoogsteen and sugar interactions, those where the nucleotides are side by side or on top of each other, are not taken into account by conventional modelling algorithms. The result can be incomplete or erroneous models which can mislead researchers.

In a recent edition of Advanced Materials Magazine, Michael Bockstaller and Krzysztof Matyjaszewski demonstrate that controlling the structure of nanoparticles can “shrink” their visible size by a factor of thousands without affecting a particle’s actual physical dimension.

It's invisibility in the optical range, something that cannot be done with current metamaterials

“What we are doing is creating a novel technique to control the architecture of nanoparticles that will remedy many of the problems associated with the application of nanomaterials that are so essential to business sectors such as the aerospace and cosmetics industry,” said Bockstaller, an assistant professor of materials science and engineering at Carnegie Mellon University.

SANTA CLARA, California, March 6 /PRNewswire/ --

Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, announced the opening of its new sales and service center in Northborough, MA, in order to support its east coast customer base. Additionally, Finesse Solutions is converting its Irvine, CA facility to a service center for its west coast customer base. The company also plans on opening a European sales and service center in the summer of 2008, and additional sales and service centers in the U.S. by the end of 2008.

WASHINGTON, March 6 /PRNewswire/ --

Global power generated by nuclear reactors fell about 3.6% in calendar 2007 from the 2.8 billion megawatt-hours (MWh) recorded in 2006, according to data released by Nucleonics Week, a publication of Platts, a leading global provider of energy and commodities information.

In the otherwise lackluster 2007, US reactors set a record for nuclear power generation, with output surging to 843 million gross MWh and utilizing an average 91% of reactor capacity.

"The 2007 nuclear plant performance means about 20% of US electricity was once again generated without the carbon emissions that would otherwise contribute to global warming," said Margaret Ryan, Platts global nuclear editorial director.

It's what you always feared. Your brain actually does react differently to donuts, according to fMRI-based research led by Marsel Mesulam, M.D., a neurologist at Northwestern Memorial Hospital.

Krispy Kremes, in perhaps their first starring role in neurological research, helped lead to the discovery.

In the study, subjects were tested twice -- once after gorging on up to eight Krispy Kreme donuts until they couldn't eat anymore, and on another day after fasting for eight hours. In both sessions, people were shown pictures of donuts and screwdrivers, while researchers examined their brains in fMRI's.

NEW YORK and DUBLIN, Ireland, March 6 /PRNewswire/ --

- Transaction Joins the World's Largest Provider of Visual Localisation Software with Global Leader in Software Localisation Services and Technology

MOUNTAIN VIEW, California, March 6 /PRNewswire/ --

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the results of its Multi MERCI trial will be published in the April 2008 edition of the medical journal, Stroke. The Multi MERCI trial was the second trial studying safety and efficacy of the Merci Retrieval System(TM), a "corkscrew-type" device that is delivered into the brain and is designed to restore blood flow by engaging, capturing and removing blood clots that cause ischemic stroke. The full, peer reviewed trial results are available now to online subscribers. Stroke is published by the American Heart Association.